Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled double-blind dose-ranging study of SSR149744C versus amiodarone in atrial fibrillation/flutter
2004-001766-40Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of celivarone in Atrial fibrillation (AFib) and atrial flutter (AFL) (6 arms), sponsored by Sanofi. Primary endpoint: Time to first AF/AFL recurrence. Started Sep 2004; status: completed.
02
Drugs
celivarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2004-001766-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001766-40.